vs
奔特力系统（BSY）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是奔特力系统的1.6倍（$622.0M vs $391.6M），Royalty Pharma plc净利率更高（34.4% vs 15.0%，领先19.5%），奔特力系统同比增速更快（11.9% vs 4.8%），过去两年奔特力系统的营收复合增速更高（7.7% vs 4.6%）
奔特力系统是总部位于美国的软件开发企业，面向全球基础设施的设计、建造及运营全周期，提供软件产品授权、销售及相关技术支持服务。旗下产品覆盖建筑、工厂、土木、地理空间等领域，广泛应用于建筑工程施工及运营场景，支撑各类大型建成资产的全生命周期管理。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
BSY vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.6倍
$391.6M
营收增速更快
BSY
高出7.2%
4.8%
净利率更高
RPRX
高出19.5%
15.0%
两年增速更快
BSY
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $391.6M | $622.0M |
| 净利润 | $58.6M | $214.2M |
| 毛利率 | 81.9% | — |
| 营业利润率 | 20.0% | 62.4% |
| 净利率 | 15.0% | 34.4% |
| 营收同比 | 11.9% | 4.8% |
| 净利润同比 | 17.1% | 2.9% |
| 每股收益（稀释后） | $0.17 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BSYRPRX
| Q4 25 | $391.6M | $622.0M | ||
| Q3 25 | $375.5M | $609.3M | ||
| Q2 25 | $364.1M | $578.7M | ||
| Q1 25 | $370.5M | $568.2M | ||
| Q4 24 | $349.8M | $593.6M | ||
| Q3 24 | $335.2M | $564.7M | ||
| Q2 24 | $330.3M | $537.3M | ||
| Q1 24 | $337.8M | $568.0M |
净利润BSYRPRX
| Q4 25 | $58.6M | $214.2M | ||
| Q3 25 | $57.4M | $288.2M | ||
| Q2 25 | $70.5M | $30.2M | ||
| Q1 25 | $91.4M | $238.3M | ||
| Q4 24 | $50.1M | $208.2M | ||
| Q3 24 | $42.3M | $544.0M | ||
| Q2 24 | $72.0M | $102.0M | ||
| Q1 24 | $70.3M | $4.8M |
毛利率BSYRPRX
| Q4 25 | 81.9% | — | ||
| Q3 25 | 80.8% | — | ||
| Q2 25 | 81.1% | — | ||
| Q1 25 | 82.3% | — | ||
| Q4 24 | 80.6% | — | ||
| Q3 24 | 80.7% | — | ||
| Q2 24 | 80.9% | — | ||
| Q1 24 | 81.7% | — |
营业利润率BSYRPRX
| Q4 25 | 20.0% | 62.4% | ||
| Q3 25 | 22.5% | 70.1% | ||
| Q2 25 | 23.2% | 36.3% | ||
| Q1 25 | 31.1% | 94.0% | ||
| Q4 24 | 17.6% | 60.9% | ||
| Q3 24 | 20.5% | — | ||
| Q2 24 | 24.3% | 50.2% | ||
| Q1 24 | 27.2% | -13.0% |
净利率BSYRPRX
| Q4 25 | 15.0% | 34.4% | ||
| Q3 25 | 15.3% | 47.3% | ||
| Q2 25 | 19.4% | 5.2% | ||
| Q1 25 | 24.7% | 41.9% | ||
| Q4 24 | 14.3% | 35.1% | ||
| Q3 24 | 12.6% | 96.3% | ||
| Q2 24 | 21.8% | 19.0% | ||
| Q1 24 | 20.8% | 0.8% |
每股收益（稀释后）BSYRPRX
| Q4 25 | $0.17 | $0.49 | ||
| Q3 25 | $0.18 | $0.67 | ||
| Q2 25 | $0.22 | $0.07 | ||
| Q1 25 | $0.28 | $0.55 | ||
| Q4 24 | $0.15 | $0.46 | ||
| Q3 24 | $0.13 | $1.21 | ||
| Q2 24 | $0.22 | $0.23 | ||
| Q1 24 | $0.22 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $123.3M | $618.7M |
| 总债务越低越好 | $1.2B | $9.0B |
| 股东权益账面价值 | $1.2B | $9.7B |
| 总资产 | $3.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 1.05× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资BSYRPRX
| Q4 25 | $123.3M | $618.7M | ||
| Q3 25 | $165.4M | $938.9M | ||
| Q2 25 | $89.6M | $631.9M | ||
| Q1 25 | $83.6M | $1.1B | ||
| Q4 24 | $64.0M | $929.0M | ||
| Q3 24 | $72.2M | $950.1M | ||
| Q2 24 | $51.3M | $1.8B | ||
| Q1 24 | $141.6M | $843.0M |
总债务BSYRPRX
| Q4 25 | $1.2B | $9.0B | ||
| Q3 25 | $1.2B | $8.9B | ||
| Q2 25 | $1.2B | $8.0B | ||
| Q1 25 | $1.2B | $7.6B | ||
| Q4 24 | $1.4B | $7.6B | ||
| Q3 24 | $1.4B | $7.6B | ||
| Q2 24 | $1.3B | $7.6B | ||
| Q1 24 | $1.4B | $6.1B |
股东权益BSYRPRX
| Q4 25 | $1.2B | $9.7B | ||
| Q3 25 | $1.2B | $9.6B | ||
| Q2 25 | $1.2B | $9.5B | ||
| Q1 25 | $1.1B | $9.8B | ||
| Q4 24 | $1.0B | $10.3B | ||
| Q3 24 | $1.0B | $10.3B | ||
| Q2 24 | $984.5M | $9.8B | ||
| Q1 24 | $932.6M | $9.9B |
总资产BSYRPRX
| Q4 25 | $3.6B | $19.6B | ||
| Q3 25 | $3.5B | $19.3B | ||
| Q2 25 | $3.4B | $18.3B | ||
| Q1 25 | $3.4B | $17.6B | ||
| Q4 24 | $3.4B | $18.2B | ||
| Q3 24 | $3.4B | $18.0B | ||
| Q2 24 | $3.3B | $17.7B | ||
| Q1 24 | $3.4B | $16.1B |
负债/权益比BSYRPRX
| Q4 25 | 1.05× | 0.92× | ||
| Q3 25 | 1.04× | 0.93× | ||
| Q2 25 | 1.07× | 0.84× | ||
| Q1 25 | 1.13× | 0.78× | ||
| Q4 24 | 1.33× | 0.74× | ||
| Q3 24 | 1.37× | 0.74× | ||
| Q2 24 | 1.36× | 0.78× | ||
| Q1 24 | 1.54× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $141.6M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $136.2M | — |
| 自由现金流率自由现金流/营收 | 34.8% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | 2.41× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $520.2M | — |
8季度趋势，按日历期对齐
经营现金流BSYRPRX
| Q4 25 | $141.6M | $827.1M | ||
| Q3 25 | $116.4M | $702.6M | ||
| Q2 25 | $61.1M | $364.0M | ||
| Q1 25 | $219.4M | $596.1M | ||
| Q4 24 | $81.6M | $742.5M | ||
| Q3 24 | $86.1M | $703.6M | ||
| Q2 24 | $62.6M | $658.2M | ||
| Q1 24 | $205.0M | $664.6M |
自由现金流BSYRPRX
| Q4 25 | $136.2M | — | ||
| Q3 25 | $110.7M | — | ||
| Q2 25 | $57.0M | — | ||
| Q1 25 | $216.4M | — | ||
| Q4 24 | $76.1M | — | ||
| Q3 24 | $84.3M | — | ||
| Q2 24 | $59.5M | — | ||
| Q1 24 | $201.4M | — |
自由现金流率BSYRPRX
| Q4 25 | 34.8% | — | ||
| Q3 25 | 29.5% | — | ||
| Q2 25 | 15.7% | — | ||
| Q1 25 | 58.4% | — | ||
| Q4 24 | 21.7% | — | ||
| Q3 24 | 25.1% | — | ||
| Q2 24 | 18.0% | — | ||
| Q1 24 | 59.6% | — |
资本支出强度BSYRPRX
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 1.1% | — |
现金转化率BSYRPRX
| Q4 25 | 2.41× | 3.86× | ||
| Q3 25 | 2.03× | 2.44× | ||
| Q2 25 | 0.87× | 12.06× | ||
| Q1 25 | 2.40× | 2.50× | ||
| Q4 24 | 1.63× | 3.57× | ||
| Q3 24 | 2.03× | 1.29× | ||
| Q2 24 | 0.87× | 6.45× | ||
| Q1 24 | 2.92× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BSY
| Enterprise License Subscriptions | $163.4M | 42% |
| Term License Subscriptions | $122.7M | 31% |
| SELECT Subscriptions | $70.6M | 18% |
| Professional Services Other | $17.2M | 4% |
| Perpetual Licenses | $14.3M | 4% |
| Professional Services Recurring | $3.5M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
